Levomilnacipran hydrochloride

Levomilnacipran hydrochloride is mainly used to treat Major Depressive Disorder (MDD) in adults, working as a Serotonin-Norepinephrine Reuptake Inhibitor (SNRI) to boost mood-regulating neurotransmitters in the brain, but it’s also sometimes explored for conditions like fibromyalgia and neuropathic pain, although its main indication is depression. It is grouped under the following drug class(es): Neurotransmitter agents, Serotonin agents and SNRIs. Its therapeutic use is listed as antidepressants. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Fetzima, Savella and Joncia. Its PubChem CID is 6917778.

CAS No 175131-60-9
Molecular Formula C15H23ClN2O
Molecular Weight 282.81 g/mol
Synonyms cis-(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide;hydrochloride

Frequently Asked Questions